Insider Transactions in Q2 2022 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2022
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,596
-4.35%
|
$3,596
$1.9 P/Share
|
|
May 26
2022
|
Lisa Rojkjaer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,154
-4.86%
|
$2,154
$1.9 P/Share
|
|
May 26
2022
|
Ivor Royston |
SELL
Open market or private sale
|
Direct |
13,162
-2.14%
|
$13,162
$1.9 P/Share
|
|
May 25
2022
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+7.69%
|
-
|
|
May 25
2022
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,034
+20.0%
|
-
|
|
May 25
2022
|
Lisa Rojkjaer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,127
+8.52%
|
-
|
|
May 25
2022
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+3.94%
|
-
|